Bespak, the specialist inhalation contract development and manufacturing organisation (CDMO) today released its first Environmental, Social and Governance (ESG) update. This update provides an overview of Bespak’s actions and progress in key material topics across its value chain. It sets out its planned future steps as part of a holistic approach to sustainable operations.

Evolving regulations, as well as individual company ESG commitments, mean the pharmaceutical industry must decrease its carbon footprint, and CDMOs have a responsibility to help drive this change. Bringing together the three facets of ESG allows a business to understand its impacts in all aspects including direct and indirect impacts on the planet, people and natural ecosystems. Bespak’s ESG update is a key step in establishing transparency and accountability, as well as a path towards its sustainability goals.

Bespak has a central focus on enabling the transition to low carbon pressurised Metered Dose Inhalers (pMDIs), but beyond this, the CDMO has many initiatives underway to tackle multiple aspects of its environmental impact. The ESG update details progress that has been made in Bespak’s first year, including:

• Development of a flagship ESG strategy
• Completion of its first double-materiality assessment
• Mapping of key stakeholders and value chain
• Verification of baseline scope 1-2 greenhouse gas (GHG) emissions data
• Establishment of an ESG & Enterprise Risk Governance Framework

Chris Hirst, CEO of Bespak, said: “This ESG update marks an important early chapter for the new Bespak. It reflects the work we’ve done to begin embedding sustainability across the business, from product design and operations to the way we partner with customers and suppliers while planning for the future. It’s taken real commitment from our skilled and dedicated teams to get us here. As we look to the rest of 2025 and beyond, I’m confident we’re building on strong foundations.”

Benedicta Bakpa, Head of ESG at Bespak, commented, “Our vision is to integrate sustainability across the inhalation supply chain. This update outlines the practical steps we’re taking and the groundwork we’ve laid to turn that ambition into action. We’re building the capacity to not only to meet our sustainability commitments, but to exceed them.’’

To learn more, view the 2024 ESG Update here.